TY  - JOUR
AU  - Opazo-Rios, Lucas
AU  - Tejera-Muñoz, Antonio
AU  - Soto Catalan, Manuel
AU  - Marchant, Vanessa
AU  - Lavoz, Carolina
AU  - Mas Fontao, Sebastian
AU  - Moreno, Juan Antonio
AU  - Fierro Fernandez, Marta
AU  - Ramos, Ricardo
AU  - Suarez-Alvarez, Beatriz
AU  - Lopez-Larrea, Carlos
AU  - Ruiz-Ortega, Marta
AU  - Egido, Jesus
AU  - Rodrigues-Diez, Raul R
PY  - 2022
DO  - 10.3389/fphar.2022.778776
SN  - 1663-9812
UR  - http://hdl.handle.net/10668/20701
T2  - Frontiers in pharmacology
AB  - Diabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the last few years, there still exists a high residual risk of disease progression to end-stage...
LA  - en
PB  - Frontiers Research Foundation
KW  - BTBR ob/ob mice
KW  - Chronic kidney disease
KW  - Diabetes
KW  - Diabetic nephropaty
KW  - Inflammation
KW  - MiRNA
KW  - Type 2 diabetes
KW  - Diabetic nephropathies
KW  - Leptin
KW  - Brachyury protein
KW  - Diabetes mellitus, type 2
KW  - Kidney failure, chronic
KW  - Renal insufficiency, chronic
KW  - Immunity
TI  - Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice.
TY  - research article
VL  - 13
ER  -